UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Special] ‘I went to US to become a study doctor’
He wanted to be a study physician, but the Korean environment was not so fa...
by Song Soo-youn
|
2019-01-11 17:01
라인
Dongkoo to test stem cell therapy for diabetic foot ulcers
Dongkoo Bio & Pharma said it would conduct a clinical trial to expand the t...
by Lee Hye-seon
|
2019-01-11 15:53
라인
Nurse commits suicide after being bullied at work
A nurse at Seoul Medical Center has killed herself on Saturday due to alleg...
by Lee Min-ju
|
2019-01-11 15:52
라인
Patient’s threat to kill trainee doctor revealed belatedly
Just four days before a patient killed psychiatrist Lim Se-won at a hospita...
by Choi Gwang-seok
|
2019-01-11 11:38
라인
Pharmaceuticals present future strategy at JP Morgan Healthcare Conference
Korean pharmaceutical and biotechnology companies emphasized their competit...
by Lee Han-soo
|
2019-01-10 18:20
라인
SNUH succeeds in allogeneic hair transplant without immunosuppressant
Researchers at Seoul National University Hospital (SNUH) have discovered a ...
by Lee Han-soo
|
2019-01-10 16:06
라인
Staffs at Incheon clinic booked for involuntary manslaughter
After a patient died at a clinic in Incheon after getting an IV injection l...
by Choi Gwang-seok
|
2019-01-10 15:53
라인
Lutronic wins FDA nod for aesthetic laser
Lutronic, a leading Korean aesthetic company, said Thursday that the U.S. F...
by Lee Han-soo
|
2019-01-10 14:32
라인
Six Tamiflu takers suffered abnormalities in 5 years
Six patients who received influenza treatment Tamiflu had neuropsychiatric ...
by Song Soo-youn
|
2019-01-10 14:19
라인
Radiology technologies using AI can get reimbursement: report
A new guideline will allow hospitals to receive extra reimbursement for art...
by Song Soo-youn
|
2019-01-10 13:10
라인
Tego Science releases research results for diabetic foot ulcer treatment
Tego science said Thursday that it has confirmed the superior efficacy resu...
by Lee Han-soo
|
2019-01-10 12:48
라인
Drugmakers criticize Seoul’s decision to provide original Tamiflu to NK
Local pharmaceutical companies are expressing their disappointment as the g...
by Lee Han-soo
|
2019-01-10 11:46
라인
MSD Korea recalls HIV drug Stocrin with particular code
MSD Korea said it would recall HIV treatment Stocrin (ingredient: efavirenz...
by Lee Hye-seon
|
2019-01-10 11:46
라인
Pfizer to stop renewing risk-sharing accord for lung cancer drug
Pfizer said it would not renew its risk-sharing agreement (RSA) for Xalkori...
by Lee Han-soo
|
2019-01-10 10:40
라인
Hugel wins patent for patch-type BTX product
Hugel said Wednesday that it has registered a patent for the microstructure...
by Lee Han-soo
|
2019-01-09 16:31
라인
Alarms, emergency exits alone cannot protect physicians: expert
The latest killing of psychiatrist Lim Se-won by a patient at Kangbuk Samsu...
by Kwak Sung-sun
|
2019-01-09 15:53
라인
Patient killed psychiatrist out of delusions: police
A patient’s delusional disorder caused the patient to kill a psychiatrist a...
by Choi Gwang-seok
|
2019-01-09 14:51
라인
Hanmi to start P1 trial about diabetes combination treatment
Hanmi Pharmaceutical has received approval from the Ministry of Food and Dr...
by Lee Han-soo
|
2019-01-09 14:51
라인
Pharma Research Bio to start P1 clinical trials about BTX
Pharma Research Bio said Monday that it has received approval from the Mini...
by Lee Han-soo
|
2019-01-09 14:51
라인
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
The Korean stock market operator decided to keep Kyung Nam Pharm listed on ...
by Lee Hye-seon
|
2019-01-09 14:49
-
이전
151
152
153
154
155
156
157
158
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top